Dose-specific effects of scopolamine on canine cognition: Impairment of visuospatial memory, but not visuospatial discrimination

被引:31
作者
Araujo, JA
Chan, ADF
Winka, LL
Seymour, PA
Milgram, NW
机构
[1] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[3] Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA
基金
加拿大自然科学与工程研究理事会;
关键词
memory; behavior; cholinergic; scopolamine; animal model; aging;
D O I
10.1007/s00213-004-1777-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale. The cholinergic system is linked extensively to memory, but its exact role remains controversial. In particular, scopolamine-induced impairment in rodents is not task specific, which may be due to difficulty in developing rodent protocols to assess deficits in recent memory, in which the remembered event is brief and distinct, and/or to non-specific behavioral impairment. Objectives. The present study sought to determine whether scopolamine-induced deficits in recent memory, using a working memory task, could be dose-specifically dissociated from deficits in associative memory in dogs. Methods. A Latin-square design was used to determine the effect of scopolamine (5, 10 and 15 mug/kg; SC) on a variable delayed-non-matching-to-position (DNMP) task, which assesses visuospatial working memory. Subsequently, the minimal effective dose (15 mug/kg; SC) was administered prior to testing on a landmark discrimination task, which provides a measure of allocentric spatial ability, a black-white discrimination task, an oddity discrimination task and tests of exploratory behavior. We also investigated the effects of a 30 mug/kg dose (SC) on tests of oddity discrimination and behavioral activity. Results. A 15 mug/kg dose produced significant impairment on the DNMP task, but did not affect performance of any discrimination task and did not alter behavior on tests of open field or curiosity. A 30 mug/kg dose caused disruption on discrimination performance and on open field measures. Conclusions. Working memory performance is most sensitive to scopolamine-induced impairment and can be dissociated from scopolamine-induced deficits in discrimination performance and non-cognitive behaviors. The present results indicate that scopolamine-induced impairments of working memory in the dog can serve as a model of age-related cholinergic dysfunction.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 48 条
[1]   Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog [J].
Adams, B ;
Chan, A ;
Callahan, H ;
Siwak, C ;
Tapp, D ;
Ikeda-Douglas, C ;
Atkinson, P ;
Head, E ;
Cotman, CW ;
Milgram, NW .
BEHAVIOURAL BRAIN RESEARCH, 2000, 108 (01) :47-56
[2]   The canine as a model of human cognitive aging: Recent developments [J].
Adams, B ;
Chan, A ;
Callahan, H ;
Milgram, NW .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (05) :675-692
[3]   COMPARISON OF THE EFFECTS OF SCOPOLAMINE ADMINISTERED BEFORE AND AFTER ACQUISITION IN A TEST OF VISUAL RECOGNITION MEMORY IN MONKEYS [J].
AIGNER, TG ;
WALKER, DL ;
MISHKIN, M .
BEHAVIORAL AND NEURAL BIOLOGY, 1991, 55 (01) :61-67
[4]   EFFECTS OF DISRUPTING THE CHOLINERGIC SYSTEM ON SHORT-TERM SPATIAL MEMORY IN RATS [J].
ANDREWS, JS ;
JANSEN, JHM ;
LINDERS, S ;
PRINCEN, A .
PSYCHOPHARMACOLOGY, 1994, 115 (04) :485-494
[5]   On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis [J].
Bartus, RT .
EXPERIMENTAL NEUROLOGY, 2000, 163 (02) :495-529
[6]   SHORT-TERM-MEMORY IN RHESUS-MONKEY - DISRUPTION FROM ANTI-CHOLINERGIC SCOPOLAMINE [J].
BARTUS, RT ;
JOHNSON, HR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1976, 5 (01) :39-46
[7]   Scopolamine differentially affects memory of 8- and 16-month-old rats in the double Y-maze [J].
Biggan, SL ;
Ingles, JL ;
Beninger, RJ .
NEUROBIOLOGY OF AGING, 1996, 17 (01) :25-30
[8]   Acetylcholine: A neurotransmitter for learning and memory? [J].
Blokland, A .
BRAIN RESEARCH REVIEWS, 1995, 21 (03) :285-300
[9]   Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog [J].
Bruhwyler, J ;
Liegeois, JF ;
Geczy, J .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (01) :115-128
[10]  
Bushnell PJ, 1990, BEHAV PHARMACOL, V1, P419